Researchers from across the biomedical research community met in October to discuss solutions to the 'irreproducibility epidemic', which has been re-emphasized by new data from Novartis and Sigma-Aldrich.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Dolgin, E. Drug discoverers chart path to tackling data irreproducibility. Nat Rev Drug Discov 13, 875–876 (2014). https://doi.org/10.1038/nrd4488
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4488
This article is cited by
-
Tackling reproducibility in academic preclinical drug discovery
Nature Reviews Drug Discovery (2015)